OR WAIT null SECS
July 18, 2018
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
July 01, 2018
This article highlights 15 years of changes in biopharmaceutical manufacturing.
June 25, 2018
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
June 21, 2018
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
May 30, 2018
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 29, 2018
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.
May 16, 2018
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 10, 2018
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
April 16, 2018
A new report gives an overview of the work of the International API Inspection Program.
April 06, 2018
On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.